Neurocrine Biosciences, Inc. (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

137.96

+3.30 (2.45%)

At close: Jan 29, 2026, 4:00 PM EST

139.99

+2.03 (1.47%)

After-hours: Jan 29, 2026, 7:33 PM EST

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2012 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2012 - 2020
INGREZZA Revenue	2.47B	2.31B	Log In	Log In	Log In	Upgrade
ONGENTYS and Other Product Revenue	19.70M	17.10M	Log In	Log In	Log In	Upgrade
Total Net Product Revenue	2.66B	2.33B	Log In	Log In	Log In	Upgrade
Royalties Revenue	23.30M	18.60M	Log In	Log In	Log In	Upgrade
Milestones Revenue	-	-	Log In	Log In	Log In	Upgrade
Collaboration and Other Revenue	2.60M	6.10M	Log In	Log In	Log In	Upgrade
Total Collaboration Revenue	25.90M	24.70M	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.68B	2.36B	Log In	Log In	Log In	Upgrade

Updated Oct 28, 2025. Data Source: Fiscal.ai.